background
Jill Durocher

Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone

Published
June 30th, 2009
Type
Publication
Topic
Medical Abortion
Authors
Winikoff, Beverly, Dabash, Rasha, Akın, A., Dilbaz, B, Aktun, H., Dursun, P., Kıran, S., Aksan, G., Dogan, B.

Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75; doi:10.1080/13625180902916020

This article reports on results of a clinical trial evaluating two routes of misoprostol administration following mifepristone for early medical abortion. For gestations through 56 days since last menstrual period 400mcg of oral misoprostol performed better than a 400mcg sublingual dose when following 200mg mifepristone although not significantly so.